Browsing by SWH Author Collins, Ian M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 57  next >
PreviewIssue DateTitle / NameAuthor(s)Type
ESMO - 2024 - 233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC).pdf.jpgMay-2024233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC)Wong, V.; Baron-Hay, S.E.; De Boer, R.H.; Boyle, F.; Collins, Ian M., et alConference Paper 
The Journal of Pathology - 2022 - Posner - A comparison of DNA sequencing and gene expression profiling to assist tissue of.pdf.jpgJan-2023A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primaryPosner, Atara; Prall, Owen Wj; Sivakumaran, Tharani; Etemadamoghadam, Dariush; Thio, Niko, et alJournal Article 
Journal of the National Comprehensive Cancer Network - 2016 - A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types.pdf.jpg2016A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointmentsWong, Shu Fen; Norman, Richard; Dunning, Trisha Lynette; Ashley, David Michael; Khasraw, Mustafa, et alJournal Article 
Journal Of Thoracic Oncology - 2010 - A Lung Cancer Responding to Hormonal Therapy.pdf.jpg2010A lung cancer responding to hormonal therapyCollins, Ian M.; Nicholson, Siobhan A.; O'Byrne, Ken J.; Collins, Ian M.Journal Article 
JNCI Cancer Spectrum - 2019 - Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool.pdf.jpg2019Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolPhillips, Kelly-Anne; Liao, Yuyan; Milne, Roger L.; MacInnis, Robert, J.; Collins, Ian M., et alJournal Article 
2022Achieving equitable access to cancer care and clinical trials in regional Australia: A networked approach to expand capacity and implement COSA teletrials modelUnderhill, Craig; Long, Donna; Collins, Ian M.; Brown, Stephen; Harris, Samuel, et alConference Paper 
2020Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancerLoft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et alJournal Article 
Jan-2023Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancerLoft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et alJournal Article 
Human Reproductions - 2016 - Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.pdf.jpg2016Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutationsPhillips, Kelly-Anne; Collins, Ian M.; Milne, Roger L.; McLachlan, Sue Anne; Friedlander, Michael, et alJournal Article 
2014Assessing and managing breast cancer risk: Clinicians' current practice and future needsCollins, Ian M.; Steel, Emma; Mann, G Bruce; Emery, Jon D.; Bickerstaffe, Adrian, et alJournal Article 
BMC Cancer - 2022 - Beyond standard data collection - the promise and potential of BRAIN.pdf.jpgJun-2022Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Gately, Lucy; Drummond, Katherine; Rosenthal, Mark; Harrup, Rosemary; Dowling, Anthony, et alJournal Article 
2016Breast cancer clinical quality indicatorsPitson, Graham; Matheson, Leigh; Campbell, David; Garrard, Brooke; Collins, Ian M., et alConference Paper 
2018Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line settingConduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et alConference Paper 
2022CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohortJavaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et alConference Paper 
2012Clinical decision aids in colon cancer: a comparison of two predictive nomogramsCollins, Ian M.; Kelleher, Fergal; Stuart, Charlotte; Collins, Marnie; Kennedy, John, et alJournal Article 
2019Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two yearsMileshkin, Linda R.; Sivakumaran, Tharani; Etemadmoghadam, Dariush; Tothill, Richard; Fellowes, Andrew, et alConference Paper 
10-Nov-2023A combined analysis of two randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaGately, Lucy; Mesia, Carlos; Sepulveda, Juan; del Barco, Sonia; Pineda, Estela, et alConference Paper 
2019Consumer and clinician perspectives on personalising breast cancer prevention informationKeogh, L. A.; Steel, E.; Weideman, P.; Butow, P.; Collins, Ian M., et alJournal Article 
medRxiv - 2022 - The DNA sequencing and gene-expression profiling assists in making a tissue of origine diagnosis in cancer of unknown primary.pdf.jpgJun-2022DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primaryPosner, A.; Prall, Owen W. J.; Sivakumaran, Tharani; Etemadamoghadam, D.; Thio, N., et alJournal Article 
2013Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for research into Familial Breast cancerCollins, Ian M.; Milne, Roger L.; McLachlan, Sue Anne; Friedlander, Michael; Hickey, Martha, et alJournal Article